Editorial: Protein-RNA interplay-regulated signaling in stem cells and cancer

Front Cell Dev Biol. 2023 Oct 16:11:1304817. doi: 10.3389/fcell.2023.1304817. eCollection 2023.

¹ Laboratory of RNA Molecular Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, CAS Key Laboratory of Regenerative Biology, GIBH-CUHK Joint Research Laboratory on Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
² Institute of Precision Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
³ Department of Anaesthesia and Intensive Care, State Key Laboratory of Digestive Diseases, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
⁴ Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY, United States.
⁵ Department of Toxicology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.

No abstract available

Keywords: RNA modifications; cancer; epitranscriptome; stem cells; transcriptional regulatinon.

Publication types

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.